Mounjaro®
Starting from £179.99/mo
Start journey Learn moreYou do not need a diabetes diagnosis to get Mounjaro in the UK. Tirzepatide holds a separate UK licence for weight management in adults — issued by the MHRA independently of its diabetes approval — and the legal route to it is a private prescription following a clinical assessment. Getting Mounjaro for weight loss means seeing a prescriber who can assess whether the medicine is right for you, then obtaining it through a GPhC-registered pharmacy. This page explains exactly how that works, what the eligibility criteria look like, and how to tell a safe online service from a risky one.
At your door the next working day.
Free, tracked, plain packaging.
BMI isn't the whole story, but it's where clinicians start. Check yours in ten seconds — nothing is stored, nothing is shared.
Ten seconds. Private — nothing is stored or shared.
Your result updates live in the card alongside.
Your result
Your BMI is
—
which is in the healthy weight range
Start journeyBMI doesn't determine eligibility — only a clinician can assess whether treatment is right for you.
The problem
The nume way
clinician review. Free next working day delivery.
How it works
Tell us about your health, history and goals. Free, online, and confidential — no commitment, no waiting room.
Our team reviews your health the same day — never an algorithm, and approves your treatment there and then if eligible.
Order by 12pm, dispatched same day, delivered free the next working day — the nume Promise.
Yes, and that is worth stating plainly because many people assume the opposite. Mounjaro (tirzepatide) was licensed by the MHRA for weight management separately from its type 2 diabetes indication. The weight-loss licence covers adults with a BMI of 30 or above, or a BMI of 27 or above alongside at least one weight-related condition such as high blood pressure, high cholesterol, obstructive sleep apnoea, prediabetes, or cardiovascular disease. That licence exists regardless of whether diabetes is part of your picture. NICE formally recommended tirzepatide for NHS use in December 2024 (TA1026), and the NHS eligibility criteria are separate from the private-prescription criteria, you do not have to meet the NHS thresholds to access it privately through a regulated service. Lower BMI thresholds apply for some ethnic backgrounds under UK clinical guidance. A prescriber assesses the whole picture, not just a BMI number, so no figure alone guarantees suitability.
Mounjaro is a Prescription-Only Medicine. The only lawful route in the UK is a prescription issued by a registered prescriber who has assessed you, and if you are researching how the prescription process works when you do not already have one, it is important to understand that there are no shortcuts, and any seller offering it without a prescription is operating outside the law. The clinical assessment covers your medical history, current medicines, weight, and whether any contraindications apply. At a regulated online pharmacy such as nume, that process runs as follows: you complete a detailed health questionnaire; a GPhC-registered Independent Prescriber reviews your answers and your verified ID and weight the same day; if the medicine is clinically appropriate, a prescription is issued and your treatment is dispensed from our own GPhC-registered pharmacy (premises number 9012878, verifiable on the GPhC register). The NHS tirzepatide page sets out how the medicine works and what to expect once treatment begins, reading it before your consultation is a good idea.
If you are searching for Mounjaro online, you will find legitimate registered pharmacies alongside sellers who have no business dispensing a prescription medicine. The MHRA has publicly warned about counterfeit weight-loss pens sold via social media and unverified websites, fake pens seized in recent enforcement operations have contained insulin rather than tirzepatide, with serious consequences for people who used them. In 2025 alone, roughly 20 million doses of illegally traded weight-loss medicines (worth around £45 million) were seized, and the first illicit UK site manufacturing fake tirzepatide pens was raided. The red flags are consistent: sellers who offer Mounjaro without requiring a clinical assessment, prices significantly below the market range, and discount codes from unverifiable sources. The safe check is simple: look up any pharmacy on the GPhC register before handing over your details. You can also report a suspect seller through the MHRA Yellow Card scheme. Legitimate services make their registration number easy to find. We do. You can also read more about what to look for when buying Mounjaro online to help you compare services with confidence.
That is probably the question our prescribers hear most often, and the honest answer is that a consultation is the only way to find out for certain. The eligibility criteria cover BMI, comorbidities, and your medical history, a combination that cannot be reliably self-assessed from a webpage. If you are curious whether your BMI actually puts you in range, the NHS BMI calculator is a good starting point, and our guide on how to get Mounjaro if you do not consider yourself overweight covers some of the less obvious situations where people may still qualify. Some people search for Mounjaro having already been on it elsewhere and wanting to transfer their treatment; others are considering it for the first time and feel uncertain, that uncertainty is completely understandable. Our clinical team reviews every case individually. If you are wondering whether the medicine is suitable for a specific situation, you can also browse our FAQs or reach out via our contact page before starting. When you are ready, start your free consultation and a prescriber will give you a clear answer the same day.
The people
Superintendent Pharmacist (GPhC No. 2217101)
Accountable for the safe running of our registered pharmacy, from every dispensing check to every dispatch.
Clinical Lead (GPhC No. 2231744)
Sets our clinical standards and checks everything we publish against current MHRA guidance.
Independent Prescriber (GPhC No. 2084501)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.
Independent Prescriber (GPhC No. 2083426)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.